Radionuclide cocktails for therapy of tumours with a broad range of sizes.

被引：0
|
作者：
Zweit, J [1 ]
Nahum, A [1 ]
Gianolini, S [1 ]
Flower, M [1 ]
Flux, G [1 ]
McCready, V [1 ]
机构：
[1] INST CANC RES,ROYAL MARSDEN NHS TRUST,SUTTON,SURREY,ENGLAND
来源：
JOURNAL OF NUCLEAR MEDICINE | 1997年 / 38卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：961 / 961
页数：1
相关论文
共 50 条
  • [21] Radionuclide labeled nanocarrier for imaging guided combined radionuclide, sonodynamic, and photothermal therapy of pancreatic tumours
    An, Jie
    He, Xinyi
    Ma, Huizhu
    Li, Yanglei
    Li, Yayuan
    Zhang, Xinyu
    Shuai, Qizhi
    Wang, YinMeng
    Liu, Wen
    Li, Weihua
    Wang, Hongliang
    Wu, Zhifang
    Li, Sijin
    JOURNAL OF COLLOID AND INTERFACE SCIENCE, 2023, 642 : 789 - 799
  • [22] RADIONUCLIDE THERAPY OF CANCER - PARTICLE RANGE AND THERAPEUTIC EFFECTIVENESS
    WHELDON, TE
    NUCLEAR MEDICINE COMMUNICATIONS, 1993, 14 (06) : 408 - 410
  • [23] Combination treatments to enhance peptide receptor radionuclide therapy of neuroendocrine tumours
    Samuel Adant
    Girish M. Shah
    Jean-Mathieu Beauregard
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 907 - 921
  • [24] Pituitary function following peptide receptor radionuclide therapy for neuroendocrine tumours
    Elston, Marianne S.
    Love, Amanda
    Kevat, Dev
    Carroll, Richard
    Siow, Zhen Rong
    Pattison, Sharon
    Boyle, Veronica
    Segelov, Eva
    Strickland, Andrew H.
    Wyld, David
    Gauci, Richard
    Kennedy, Kim
    Ransom, David
    CANCER MEDICINE, 2021, 10 (23): : 8405 - 8411
  • [25] The role of peptide receptor radionuclide therapy in patients with lung neuroendocrine tumours
    Filice, Angelina
    Fraternali, Alessandro
    Fioroni, Federica
    Froio, Armando
    Di Paolo, Maria Liberata
    Casali, Massimiliano
    Roncali, Massimo
    Grassi, Elisa
    Asti, Mattia
    Versari, Annibale
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [26] Receptor radionuclide therapy with 177Lu-DOTATATE in neuroendocrine tumours
    Bodei, L.
    Cremonesi, M.
    Grana, C.
    Bartolomei, M.
    Baio, S.
    Bufi, G.
    Fiorenza, M.
    Obenaus, E.
    Paganelli, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S214 - S214
  • [27] Peptide receptor radionuclide therapy as neoadjuvant treatment in pancreatic neuroendocrine tumours
    Prospero, I.
    Ferreira, G.
    Ferro, J. C.
    Barbosa, D.
    Silva, D. G.
    Fontao de Castro, S.
    Teixeira, J. P.
    Duarte, H.
    Lucena Sampaio, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S220 - S220
  • [28] Peptide receptor radionuclide therapy for neuroendocrine tumours: standardized and randomized, or personalized?
    Michael S. Hofman
    Rodney J. Hicks
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 211 - 213
  • [29] Advances in nuclear oncology: Microspheres for internal Radionuclide therapy of liver tumours
    Nijsen, JFW
    van het Schip, AD
    Hennink, WE
    Rook, DW
    van Rijk, PP
    de Klerk, JMH
    CURRENT MEDICINAL CHEMISTRY, 2002, 9 (01) : 73 - 82
  • [30] Peptide receptor radionuclide therapy for neuroendocrine tumours: standardized and randomized, or personalized?
    Hofman, Michael S.
    Hicks, Rodney J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (02) : 211 - 213
12345